Evaluation of pindolol in the treatment of hypertension

Twenty hypertensive patients were treated for 15 weeks with pindolol, a new anti-hypertensive agent. Blood pressure while resting and after standing was reduced in all patients whether previously treated with an antihypertensive agent or not. All patients completed the study and no side-effects were reported. Laboratory tests showed no abnormalities and pindolol was very well tolerated in all patients. The dose of other antihypertensive agents was reduced in 7 patients.